Drug Type Small molecule drug |
Synonyms RU-350 |
Target |
Mechanism Serotonin reuptake inhibitors, VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC19H29NO3 |
InChIKeyWEQLWGNDNRARGE-UAGQMJEPSA-N |
CAS Registry862377-27-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Phase 1 | GB | - | |
Huntington Disease | Phase 1 | - | - | |
Huntington Disease | Phase 1 | - | - |